Mark Weiser, MD

  • 5Articles
  • 18.5KReads
  • 2004–2022Active
  • 48Collaborators
  • 165Citations

About

Mark Weiser, MD, is affiliated with the Department of Psychiatry at Sheba Medical Center and the Sackler School of Medicine at Tel Aviv University in Israel. With publications spanning from 2004 to 2022, Weiser has contributed research focused on schizophrenia and schizoaffective disorders, child and adolescent psychiatry, and suicide. His work includes clinical trials investigating pharmacological treatments and studies examining health care utilization prior to suicide among military personnel.

Publications

JCP
Add-on Pramipexole for Schizophrenia
Original Research

Add-on Pramipexole for Schizophrenia

August 1, 2022

Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test...
, , , et al
JCP
Original Research

Raloxifene in Postmenopausal Women With Schizophrenia

August 23, 2017

The estrogen protection hypothesis of schizophrenia was introduced in the late 1980s to explain  gender-related differences in epidemiology and clinical features. This study examines whether raloxifene, an estrogen agonist,...
, , , et al
JCP
Article

Primary Health Care Utilization Prior to Suicide: A Retrospective Case-Control Study Among Active-Duty Military Personnel

August 26, 2014

, , , et al
JCP
Original Research

A Multicenter, Add-On Randomized Controlled Trial of Low-Dose d-Serine for Negative and Cognitive Symptoms of Schizophrenia

June 15, 2012

, , , et al
JCP
Original Research

Body Mass Index and Future Schizophrenia in Israeli Male Adolescents

November 1, 2004

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe